MS Queensland works closely and collaboratively with our national research arm, MS Research Australia, and provides funding towards MS Research Australia’s research effort. MS Research Australia implements an informed scientific agenda to accelerate advances that will prevent, better treat and ultimately cure multiple sclerosis.
As a part of the research effort, MS Research Australia provides updates on some of the major breakthroughs in MS Research.
Anti-EBV Trial Shows Promise in Progressive MS
20 November, 2018
A treatment called ‘adoptive T cell immunotherapy’ – which targets the Epstein Barr virus (EBV) – was shown to be safe in a group of 10 patients with primary and secondary MS in a small phase I (safety) trial
Larger studies are now underway to test the safety and effectiveness of the treatment
Fibrin is a protein that accumulates in the brain in diseases such as MS and Alzheimer’s disease and may play a role in tissue damage, but due to its essential role in blood clotting, successful treatments that can safely block fibrin in the brain have remained elusive.
While still in the early stages, if this research can be validated in humans, it may represent the first step in developing a new type of treatment for damage seen in MS and other diseases.